RecruitingNot Applicable

the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic Surgery

China112 participantsStarted 2025-11-01

Plain-language summary

The purpose of this clinical trial is to understand the effect of percutaneous acupoint electrical stimulation on postoperative gastrointestinal dysfunction. It will also investigate the safety of percutaneous acupoint electrical stimulation. The main questions that this trial aims to answer are: Can percutaneous acupoint electrical stimulation alleviate postoperative gastrointestinal dysfunction? Through which mechanisms do they function? Participants will: Preoperatively, patients were either given or not given percutaneous acupoint electrical stimulation. Record their symptoms and biological indicators within 5 days after the operation.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years * BMI \< 28 kg/m2 * ASA classification is I-III grade * Laparoscopic urological procedures under general anesthesia, including but not limited to laparoscopic nephrectomy and laparoscopic radical prostatectomy for prostate cancer * Normal comprehension ability, and the patient or his/her family members can cooperate in filling out the questionnaire * Voluntary to sign the informed consent form Exclusion Criteria: * Comprehensive assessment of severe cardiovascular, pulmonary and cerebrovascular diseases (such as severe coronary heart disease, valve diseases, respiratory failure, cerebral hemorrhage, cerebral infarction, etc.) * Preoperative use of analgesic and gastrointestinal motility drugs * TEAS contraindications (having electronic devices in the body, skin damage or infection at the stimulation site) * Previous history of TEAS or electro-acupuncture treatment * Previous history of gastrointestinal surgery, long-term gastrointestinal motility disorders and severe intestinal diseases * Pregnancy

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

I-FEED(Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms)Score

Timeframe: Three days after the operation

Trial details

NCT IDNCT07133620

SponsorThe First Affiliated Hospital of Xiamen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11-01

Contact for this trial

Linhong Wang

+86-13807548496 2797424071@qq.com

View on ClinicalTrials.gov More Postoperative Gastrointestinal Dysfunction (POGD) trials